enVVeno Medical (NVNO) Depreciation & Amortization (CF) (2017 - 2026)

enVVeno Medical's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $31000.0 for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 22.5% year-over-year to $31000.0; the TTM figure through Mar 2026 stood at $127000.0 (down 27.01% YoY), while the FY2025 annual figure was $136000.0, down 28.04% from the prior year.
• Depreciation & Amortization (CF) was $31000.0 for Q1 2026 at enVVeno Medical, roughly flat from $31000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $56000.0 in Q3 2023 to a low of $31000.0 in Q3 2025.
• Historically, Depreciation & Amortization (CF) has averaged $46352.9 across 5 years, with a median of $51000.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 82.14% in 2022, then sank 33.33% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $54000.0 in 2022, then climbed by 1.85% to $55000.0 in 2023, then slipped by 27.27% to $40000.0 in 2024, then fell by 22.5% to $31000.0 in 2025, then changed by 0.0% to $31000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $31000.0 (Q1 2026), $31000.0 (Q4 2025), and $31000.0 (Q3 2025), per Business Quant data.